ื™ื•ื ืฉืœื™ืฉื™, 25 ืื•ื’ื•ืกื˜ 2026

Neurodevelopmental Disorders

ืžืคื” ื’ื ื˜ื™ืช ื—ื“ืฉื” ื—ื•ืฉืคืช ืจืžื–ื™ื ืœืื•ื˜ื™ื–ื ื•ื”ืคืจืขืช ืžื•ื— ื ื“ื™ืจื”
ื‘ืจื™ืื•ืช 8 ื—ื•ื“ืฉื™ื ืœืคื ื™

ืžืคื” ื’ื ื˜ื™ืช ื—ื“ืฉื” ื—ื•ืฉืคืช ืจืžื–ื™ื ืœืื•ื˜ื™ื–ื ื•ื”ืคืจืขืช ืžื•ื— ื ื“ื™ืจื”

ืžื“ืขื ื™ื ื‘ื”ื•ื‘ืœื” ื™ืฉืจืืœื™ืช ืคื™ืชื—ื• ืžืคื” ื’ื ื˜ื™ืช ื—ื“ืฉื”, ืฉื–ื™ื”ืชื” ืžืื•ืช ื’ื ื™ื ื”ื—ื™ื•ื ื™ื™ื ืœื”ืชืคืชื—ื•ืช ืžื•ืงื“ืžืช ืฉืœ ื”ืžื•ื—. ืžื—ืงืจ ื–ื” ืžืฆื™ืข ืจืžื–ื™ื ื—ื™ื•ื ื™ื™ื ืœ.

ืžืงื•ืจ: ืกื•ื›ื ื•ืช ื”ื™ื“ื™ืขื•ืช TPS